RYTM
NASDAQ · Biotechnology
Rhythm Pharmaceuticals Inc
$110.64
+5.62 (+5.35%)
Performance
1D
—
1W
+18.41%
1M
+21.88%
3M
-4.19%
6M
+21.17%
1Y
+13.33%
YTD
+5.36%
Open$106.06
Previous Close$105.02
Day High$112.12
Day Low$104.31
52W High$122.20
52W Low$74.50
Volume—
Avg Volume2.37M
Market Cap7.63B
P/E Ratio—
EPS$-3.05
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$96.15
Above
SMA 200
$97.01
Above
RSI (14)
71
Overbought
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
24 analysts
Price Target
-8.6% upside
Current
$110.64
$110.64
Target
$101.09
$101.09
$80.78
$101.09 avg
$123.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 201.34M | 975.71M | 873.25M |
| Net Income | -208,537,811 | -22,144,056 | -23,253,892 |
| Profit Margin | -103.6% | -2.3% | -2.7% |
| EBITDA | -202,318,359 | -26,213,634 | -24,112,007 |
| Free Cash Flow | — | -20,824,615 | -25,629,049 |
| Rev Growth | +100.2% | -2.7% | +8.2% |
| Debt/Equity | 0.40 | 0.40 | 0.36 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |